BENDAMUSTINE Side Effects

6924252-9 | Hypotension, Syncope
on Aug 11, 2010 Male patient from UNITED STATES , 77 years of age, weighting 246.9 lb, was treated with Bendamustine (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, syncope. Bendamustine dosage: 918 Mg Other Iv.

6919786-7 | Asthenia, Decreased Appetite, Dehydration, Diarrhoea, Dyspnoea, Fatigue, Headache, Hypokalaemia, Hypotension
Patient was taking Bendamustine (View Usage). Patient had the following side effects: asthenia, decreased appetite, dehydration, diarrhoea, dyspnoea, fatigue, headache (What is headache?), hypokalaemia, hypotension on Aug 10, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, weighting 159.0 lb, was diagnosed with breast cancer metastatic and. Bendamustine dosage: Days 1+2, Q21 Days Iv. During the same period patient was treated with TARCEVA (Days 5-21, Q21 Days Po) (View Tarceva Review and Tarceva Label ). Patient was hospitalized.

6811186-3 | Acute Respiratory Distress Syndrome, Atrial Fibrillation, Collapse Of Lung, Fall, Lobar Pneumonia
Adverse event was reported on Jun 29, 2010 by a Male patient taking Bendamustine (View Usage) (Dosage: 280 Mg Day 1 + Day 2 Of A 21 Day Cycle) . Location: UNITED STATES , 64 years of age, weighting 259.0 lb, After Bendamustine was administered, patient had the following side effects: acute respiratory distress syndrome, atrial fibrillation (What is atrial fibrillation?), collapse of lung, fall (What is fall?), lobar pneumonia. Patient was hospitalized.

6807686-2 | Lobar Pneumonia, Pulmonary Embolism
on Jun 28, 2010 Male patient from UNITED STATES , 64 years of age, weighting 259.0 lb, was treated with Bendamustine (View Usage). Patient experienced the following unwanted or unexpected effects: lobar pneumonia, pulmonary embolism (What is pulmonary embolism?). Bendamustine dosage: 280 Mg Iv D1 And D2 Of A 21 Day Cycle. Patient was hospitalized.


6796255-9 | Hot Flush, Hyperkalaemia, Hyperphosphataemia, Hypocalcaemia, Renal Failure, Thrombocytopenia, Tumour Lysis Syndrome, Weight Decreased
on Jun 24, 2010 Male patient from UNITED STATES , 62 years of age, weighting 174.2 lb, was diagnosed with mantle cell lymphoma and was treated with Bendamustine (View Usage). Patient had the following side effects: hot flush, hyperkalaemia, hyperphosphataemia, hypocalcaemia, renal failure, thrombocytopenia, tumour lysis syndrome, weight decreased. Bendamustine dosage: 180 Mg Every Day Iv. During the same period patient was treated with RITUXIMAB (750 Mg Once Iv) (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6785513-X | Hypercoagulation, Pulmonary Embolism
Patient was taking Bendamustine (View Usage). After Bendamustine was administered, patient had the following side effects: hypercoagulation, pulmonary embolism (What is pulmonary embolism?) on Jun 21, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 259.0 lb, . Bendamustine dosage: 280 Mg D1 And D2 Of Every 21 Day Cycle. Patient was hospitalized.

6760552-3 | Hypercoagulation, Oncologic Complication, Pulmonary Embolism
Adverse event was reported on Jun 07, 2010 by a Female patient taking Bendamustine (View Usage) (Dosage: 280 Mg, Iv, D1 And D2 Of Every 21 Day Cycle) . Location: UNITED STATES , 64 years of age, weighting 259.0 lb, Patient experienced the following unwanted or unexpected effects: hypercoagulation, oncologic complication, pulmonary embolism (What is pulmonary embolism?). Patient was hospitalized.

6719680-0 | Asthenia, Dizziness, Ear Pain, Febrile Neutropenia
on May 10, 2010 Male patient from UNITED STATES , 66 years of age, weighting 176.1 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Bendamustine (View Usage). Patient had the following side effects: asthenia, dizziness (What is dizziness?), ear pain, febrile neutropenia. Bendamustine dosage: 177 Mg 2 Time Iv. During the same period patient was treated with BENDAMUSTINE 0.3 MG/DL MILLENNIUM (View Bendamustine 0.3 Mg/dl Millennium Review and Bendamustine 0.3 Mg/dl Millennium Label ), RITUXAN (739 Mg Once Iv) (View Rituxan Review and Rituxan Label ). Patient was hospitalized.

6710718-3 | Neutropenia, Pneumonitis, Pyrexia, White Blood Cell Count Decreased
on Mar 08, 2010 Female patient from UNITED STATES , 76 years of age, weighting 117.3 lb, was treated with Bendamustine (View Usage). After Bendamustine was administered, patient had the following side effects: neutropenia, pneumonitis, pyrexia, white blood cell count decreased. Bendamustine dosage: Mg D 1, 2 Iv Q 21 Days. Patient was hospitalized.

6705987-X | Dyspnoea, Interstitial Lung Disease, Oxygen Saturation Decreased, Pneumonia, Productive Cough, Sputum Discoloured, Troponin Increased
Patient was taking Bendamustine (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, interstitial lung disease, oxygen saturation decreased, pneumonia (What is pneumonia?), productive cough, sputum discoloured, troponin increased on Apr 30, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 193.0 lb, . Bendamustine dosage: 120 Mg/m2 D1,2 Q21 Days. Patient was hospitalized.

6666829-4 | Febrile Neutropenia
Adverse event was reported on Apr 01, 2010 by a Male patient taking Bendamustine (View Usage) (Dosage: 200 Mg Every Day Iv) was diagnosed with neoplasm and. Location: UNITED STATES , 69 years of age, weighting 185.2 lb, Patient had the following side effects: febrile neutropenia. During the same period patient was treated with RITUXIMAB (100 Mg Once Iv) (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6600604-1 | Blood Glucose Decreased, Dialysis, Hypoglycaemia, Pneumonia, Renal Failure Acute, Unresponsive To Stimuli
on Feb 23, 2010 Male patient from UNITED STATES , 43 years of age, weighting 177.5 lb, was treated with Bendamustine (View Usage). After Bendamustine was administered, patient had the following side effects: blood glucose decreased, dialysis (What is dialysis?), hypoglycaemia, pneumonia (What is pneumonia?), renal failure acute, unresponsive to stimuli. Bendamustine dosage: 223 Mg D 1+2 Iv. Patient was hospitalized.

6538524-3 | Arthralgia, Back Pain, Groin Pain, Urinary Tract Infection
on Jan 13, 2010 Female patient from UNITED STATES , 56 years of age, weighting 178.4 lb, was treated with Bendamustine (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, back pain (What is back pain?), groin pain, urinary tract infection (What is urinary tract infection?). Bendamustine dosage: 238 Mg Iv Over Day 1+2. Patient was hospitalized.

6445152-7 | Aphthous Stomatitis
Patient was taking Bendamustine (View Usage). Patient had the following side effects: aphthous stomatitis on Nov 16, 2009 from UNITED STATES Additional patient health information: Female patient , 72 years of age, was diagnosed with chronic lymphocytic leukaemia and. Bendamustine dosage: 130 Mg Other Iv. During the same period patient was treated with RITUXIMAB (700 Mg Other Iv) (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6312166-7 | Paraneoplastic Pemphigus, Stevens-johnson Syndrome
Adverse event was reported on Aug 13, 2009 by a Male patient taking Bendamustine (View Usage) (Dosage: 165 Mg Qd Iv Drip) was diagnosed with b-cell lymphoma and. Location: UNITED STATES , 73 years of age, weighting 138.9 lb, After Bendamustine was administered, patient had the following side effects: paraneoplastic pemphigus, stevens-johnson syndrome. Patient was hospitalized.

6112025-9 | Alpha Haemolytic Streptococcal Infection, Anaemia, Atelectasis, Dehydration, Hydronephrosis, Lymphadenopathy, Lymphoma, Myocardial Ischaemia
on Mar 04, 2009 Male patient from UNITED STATES , 62 years of age, weighting 160.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine (View Usage). Patient experienced the following unwanted or unexpected effects: alpha haemolytic streptococcal infection, anaemia, atelectasis, dehydration, hydronephrosis, lymphadenopathy, lymphoma (What is lymphoma?), myocardial ischaemia. Bendamustine dosage: 90 Mg/m2 D1 And D2 Q35 Days Intravenous. During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6106888-0 | Abdominal Distension, Abdominal Pain Upper, Cough, Fatigue, Lymphadenopathy, Myalgia, Neutrophil Count Decreased, Nocardiosis, Organising Pneumonia
on Feb 26, 2009 Female patient from UNITED STATES , 52 years of age, weighting 165.0 lb, was diagnosed with b-cell lymphoma, non-hodgkin's lymphoma and was treated with Bendamustine (View Usage). Patient had the following side effects: abdominal distension, abdominal pain upper, cough, fatigue, lymphadenopathy, myalgia, neutrophil count decreased, nocardiosis, organising pneumonia. Bendamustine dosage: 70 Mg/m2 Day 2, Every 35 Days X 5 Cycles Intravenous. During the same period patient was treated with RITUXAN (375 Mg/m2 Every 35 Days X 5 Cycles Intravenous) (View Rituxan Review and Rituxan Label ), VELCADE (View Velcade Review and Velcade Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LASIX /0032601/ (View Lasix /0032601/ Review and Lasix /0032601/ Label ), NEXIUM (View Nexium Review and Nexium Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ). Patient was hospitalized.

6106887-9 | Atelectasis, Dehydration, Heart Rate Increased, Lung Infiltration, Lymphoma, Malignant Neoplasm Progression, Pleural Effusion
Patient was taking Bendamustine (View Usage). After Bendamustine was administered, patient had the following side effects: atelectasis, dehydration, heart rate increased, lung infiltration, lymphoma (What is lymphoma?), malignant neoplasm progression, pleural effusion on Feb 26, 2009 from UNITED STATES Additional patient health information: Male patient , 62 years of age, weighting 160.0 lb, was diagnosed with non-hodgkin's lymphoma and. Bendamustine dosage: 90 Mg/m2 D1 Nd D2 Q35 Days Intravenous. During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6104696-8 | Abdominal Distension, Abdominal Pain Upper, Biopsy Bone Marrow Abnormal, Cough, Fatigue, Lymphadenopathy, Malaise, Myalgia, Neutrophil Count Decreased
Adverse event was reported on Feb 24, 2009 by a Female patient taking Bendamustine (View Usage) (Dosage: 70 Mg/m2 Day 2, Every 35 Days X 5 Cycles Intravenous) was diagnosed with b-cell lymphoma, non-hodgkin's lymphoma and. Location: UNITED STATES , 52 years of age, weighting 165.0 lb, Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain upper, biopsy bone marrow abnormal, cough, fatigue, lymphadenopathy, malaise, myalgia, neutrophil count decreased. During the same period patient was treated with RITUXAN (375 Mg/m2 Every Days X Cycles Intravenous) (View Rituxan Review and Rituxan Label ), VELCADE (View Velcade Review and Velcade Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LASIX (View Lasix Review and Lasix Label ), NEXIUM (View Nexium Review and Nexium Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ). Patient was hospitalized.

6097316-2 | Injection Site Pain
on Feb 26, 2009 Male patient from UNITED STATES , 45 years of age, was treated with Bendamustine (View Usage). Patient had the following side effects: injection site pain. Bendamustine dosage: .

6091153-0 | Anaemia Haemolytic Autoimmune, Cough, Dizziness, Heart Rate Increased, Immune System Disorder, Malaise, Oropharyngeal Pain, Pyrexia, Viral Infection
on Feb 06, 2009 Male patient from JAPAN , 67 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine (View Usage). After Bendamustine was administered, patient had the following side effects: anaemia haemolytic autoimmune, cough, dizziness (What is dizziness?), heart rate increased, immune system disorder, malaise, oropharyngeal pain, pyrexia, viral infection (What is viral infection?). Bendamustine dosage: 120 Mg/kg First Thru Fourth Cycle Qd Intravenous. During the same period patient was treated with ACYCLOVIR (200 Mg Oral) (View Acyclovir Review and Acyclovir Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), MECOBALAMIN (View Mecobalamin Review and Mecobalamin Label ), ADENOSINE (View Adenosine Review and Adenosine Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ). Patient was hospitalized.

6090773-7 | Diarrhoea, Hypotension, Oedema Peripheral, Tumour Lysis Syndrome
Patient was taking Bendamustine (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, hypotension, oedema peripheral, tumour lysis syndrome on Feb 17, 2009 from UNITED STATES Additional patient health information: Male patient , 63 years of age, weighting 175.9 lb, was diagnosed with lymphoma (What is lymphoma?) and. Bendamustine dosage: 180 Mg Qd Intravenous. During the same period patient was treated with BORTEZOMIB (View Bortezomib Review and Bortezomib Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), ZOFRAN (View Zofran Review and Zofran Label ), COMPAZINE /00013302/ (View Compazine /00013302/ Review and Compazine /00013302/ Label ), TYLENOL /00724201/ (View Tylenol /00724201/ Review and Tylenol /00724201/ Label ), MEPRAZOL (View Meprazol Review and Meprazol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6071764-9 | Anaemia Haemolytic Autoimmune, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Bilirubin Unconjugated Increased, Blood Lactate Dehydrogenase Increased, Blood Urea Increased, Brain Natriuretic Peptide Increased, C-reactive Protein Increased, Cough
Adverse event was reported on Nov 12, 2008 by a Male patient taking Bendamustine (View Usage) (Dosage: 120 Mg/kg First Thru Fourth Cycle Qd Intravenous) was diagnosed with non-hodgkin's lymphoma and. Location: JAPAN , 67 years of age, Patient had the following side effects: anaemia haemolytic autoimmune, aspartate aminotransferase increased, blood bilirubin increased, blood bilirubin unconjugated increased, blood lactate dehydrogenase increased, blood urea increased, brain natriuretic peptide increased, c-reactive protein increased, cough. During the same period patient was treated with ACYCLOVIR (200 Mg) (View Acyclovir Review and Acyclovir Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), MECOBALAMIN (View Mecobalamin Review and Mecobalamin Label ), ADENOSINE (View Adenosine Review and Adenosine Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ). Patient was hospitalized.

6058086-7 | Alanine Aminotransferase Increased, Anaemia, Duodenal Ulcer, Erosive Duodenitis, Gastritis Erosive, Hypotension, Loss Of Consciousness, Neutrophil Count Decreased, Syncope
on Jan 21, 2009 Male patient from UNITED STATES , 55 years of age, weighting 211.6 lb, was diagnosed with lymphoma (What is lymphoma?) and was treated with Bendamustine (View Usage). After Bendamustine was administered, patient had the following side effects: alanine aminotransferase increased, anaemia, duodenal ulcer, erosive duodenitis, gastritis erosive, hypotension, loss of consciousness, neutrophil count decreased, syncope. Bendamustine dosage: 194 Mg Days 1 And 2 Intravenous. During the same period patient was treated with VELCADE (3.5 Mg Days 1, 8, 15 And 22 Intravenous) (View Velcade Review and Velcade Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), LYRICA (View Lyrica Review and Lyrica Label ), MORPHINE (View Morphine Review and Morphine Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ). Patient was hospitalized.

6052841-5 | Alanine Aminotransferase Increased, Anaemia, Duodenal Ulcer, Erosive Duodenitis, Gastritis Erosive, Gastrointestinal Ulcer Haemorrhage, Haematemesis, Hypophagia, Hypotension
on Jan 15, 2009 Male patient from UNITED STATES , 55 years of age, weighting 212.5 lb, was diagnosed with lymphoma (What is lymphoma?) and was treated with Bendamustine (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anaemia, duodenal ulcer, erosive duodenitis, gastritis erosive, gastrointestinal ulcer haemorrhage, haematemesis, hypophagia, hypotension. Bendamustine dosage: 194 Mg Days 1 And 2 Intravenous. During the same period patient was treated with VELCADE (3.5 Mg Days 1, 8, 15 And 22 Intravenous) (View Velcade Review and Velcade Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), LYRICA (View Lyrica Review and Lyrica Label ), MORPHINE (View Morphine Review and Morphine Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ). Patient was hospitalized.

6032681-3 | Depressed Level Of Consciousness, Fluid Intake Reduced, Hypophagia, Ulcer Haemorrhage, Upper Gastrointestinal Haemorrhage
Patient was taking Bendamustine (View Usage). Patient had the following side effects: depressed level of consciousness, fluid intake reduced, hypophagia, ulcer haemorrhage, upper gastrointestinal haemorrhage on Dec 30, 2008 from UNITED STATES Additional patient health information: Male patient , 55 years of age, weighting 212.5 lb, was diagnosed with lymphoma (What is lymphoma?) and. Bendamustine dosage: 194 Mg Days 1 And 2 Intravenous. During the same period patient was treated with VELCADE (3.5 Mg Days 1, 8, 15 And 22 Intravenous) (View Velcade Review and Velcade Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6024191-4 | Alopecia, Anaemia, Aortic Arteriosclerosis, Arteriosclerosis Coronary Artery, Ascites, Bacterial Sepsis, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Glucose Increased
Adverse event was reported on Dec 17, 2008 by a Female patient taking Bendamustine (View Usage) (Dosage: 90 Mg/m2 Days 1 + 4 Intravenous) was diagnosed with b-cell lymphoma and. Location: UNITED STATES , 62 years of age, weighting 175.5 lb, After Bendamustine was administered, patient had the following side effects: alopecia, anaemia, aortic arteriosclerosis, arteriosclerosis coronary artery, ascites, bacterial sepsis, blood alkaline phosphatase increased, blood bilirubin increased, blood glucose increased. During the same period patient was treated with BORTEZOMIB (1.3 Mg/m2 Days 1, 4, 8, 11 Intravenous) (View Bortezomib Review and Bortezomib Label ), RITUXAN (View Rituxan Review and Rituxan Label ), ZAROXOLYN (View Zaroxolyn Review and Zaroxolyn Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), MYLANTA (View Mylanta Review and Mylanta Label ), FLONASE (View Flonase Review and Flonase Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), LORTAB (View Lortab Review and Lortab Label ). Patient was hospitalized.

6005061-4 | Haemolytic Anaemia, Rheumatoid Arthritis
on Dec 08, 2008 Male patient from UNITED STATES , 63 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Bendamustine (View Usage). Patient experienced the following unwanted or unexpected effects: haemolytic anaemia, rheumatoid arthritis (What is rheumatoid arthritis?). Bendamustine dosage: 1st Cycle Intravenous. Patient was hospitalized.

5994505-X | Cardiac Failure Congestive, Cardiomegaly, Electrocardiogram St Segment Abnormal, Palpitations, Pericardial Effusion, Pleural Effusion, Sinus Tachycardia, Wheezing
on Sep 19, 2008 Female patient from JAPAN , 41 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine (View Usage). Patient had the following side effects: cardiac failure congestive, cardiomegaly, electrocardiogram st segment abnormal, palpitations, pericardial effusion, pleural effusion, sinus tachycardia, wheezing. Bendamustine dosage: 120 Mg/m2 First Thru Sixth Cycle Qd Intravenous Drip. Patient was hospitalized.

5988789-1 | Anaemia Haemolytic Autoimmune, Infection, Pyrexia, Viral Infection
Patient was taking Bendamustine (View Usage). After Bendamustine was administered, patient had the following side effects: anaemia haemolytic autoimmune, infection (What is infection?), pyrexia, viral infection (What is viral infection?) on Nov 06, 2008 from JAPAN Additional patient health information: Male patient , 67 years of age, was diagnosed with non-hodgkin's lymphoma and. Bendamustine dosage: 120 Mg/kg First Thru Fourth Cycle Qd Intravenous. During the same period patient was treated with BANDAMUSTINE (90 Mg/kg Fifth And Sixth Cycle Qd Intravenous) (View Bandamustine Review and Bandamustine Label ). Patient was hospitalized.

5948346-X | Anaemia, Pancytopenia
Adverse event was reported on Nov 10, 2008 by a Male patient taking Bendamustine (View Usage) (Dosage: ) was diagnosed with chronic lymphocytic leukaemia and. Location: UNITED STATES , weighting 167.0 lb, Patient experienced the following unwanted or unexpected effects: anaemia, pancytopenia. Patient was hospitalized.

5912988-8 | Acute Respiratory Failure, Adrenal Adenoma, Anaemia, Arteriosclerosis Coronary Artery, Atelectasis, Cardiac Failure Congestive, Constipation, Diverticulum, Hypotension
on Sep 12, 2008 Male patient from UNITED STATES , 84 years of age, weighting 200.6 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine (View Usage). Patient had the following side effects: acute respiratory failure, adrenal adenoma, anaemia, arteriosclerosis coronary artery, atelectasis, cardiac failure congestive, constipation (What is constipation?), diverticulum, hypotension. Bendamustine dosage: 182 Mg Days 1 And 4, Q 28 Days Intravenous. During the same period patient was treated with RITUXAN (View Rituxan Review and Rituxan Label ), VELCADE (View Velcade Review and Velcade Label ), NORVASC (View Norvasc Review and Norvasc Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ZOCOR (View Zocor Review and Zocor Label ), RYTHMOL (View Rythmol Review and Rythmol Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

5892463-X | Acute Respiratory Failure, Anaemia, Arteriosclerosis Coronary Artery, Atelectasis, Cardiac Failure Congestive, Hypotension, International Normalised Ratio Increased, Lobar Pneumonia, Lymphadenopathy
on Sep 12, 2008 Male patient from UNITED STATES , 84 years of age, weighting 200.6 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine (View Usage). After Bendamustine was administered, patient had the following side effects: acute respiratory failure, anaemia, arteriosclerosis coronary artery, atelectasis, cardiac failure congestive, hypotension, international normalised ratio increased, lobar pneumonia, lymphadenopathy. Bendamustine dosage: 182 Mg Days 1 And 4, Q 28 Days Intravenous. During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), BORTEZOMIB (View Bortezomib Review and Bortezomib Label ), NORVASC (View Norvasc Review and Norvasc Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ZOCOR (View Zocor Review and Zocor Label ), RYTHMOL (View Rythmol Review and Rythmol Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

5891527-4 | Agranulocytosis, Herpes Zoster, Jc Virus Infection, Progressive Multifocal Leukoencephalopathy
Patient was taking Bendamustine (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, herpes zoster, jc virus infection, progressive multifocal leukoencephalopathy on Sep 08, 2008 from GERMANY Additional patient health information: Female patient , 66 years of age, was diagnosed with non-hodgkin's lymphoma recurrent and. Bendamustine dosage: Cyclic Intravenous. During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

5827865-0 | Asthma, Reversible Airways Obstruction
Adverse event was reported on Jul 01, 2008 by a Male patient taking Bendamustine (View Usage) (Dosage: 120 Mg/m2 Cycle One Qd Intravenous Drip) was diagnosed with non-hodgkin's lymphoma and. Location: JAPAN , 58 years of age, Patient had the following side effects: asthma (What is asthma?), reversible airways obstruction. Patient was hospitalized.

5807516-1 | Febrile Neutropenia
on Jul 09, 2008 Male patient from UNITED STATES , 59 years of age, weighting 185.2 lb, was diagnosed with neoplasm malignant and was treated with Bendamustine (View Usage). After Bendamustine was administered, patient had the following side effects: febrile neutropenia. Bendamustine dosage: 100 Mg Every Day Iv. Patient was hospitalized.

5039466-5 | Dental Treatment, Gingival Ulceration, Osteonecrosis, Periodontitis
on Nov 03, 2004 Male patient from GERMANY , 88 years of age, weighting 127.9 lb, was diagnosed with plasmacytoma, multiple myeloma (What is multiple myeloma?) and was treated with Bendamustine (View Usage). Patient experienced the following unwanted or unexpected effects: dental treatment, gingival ulceration, osteonecrosis (What is osteonecrosis?), periodontitis. Bendamustine dosage: 75 Mg, Qmo. During the same period patient was treated with PREDNISOLONE (60 Mg, Qmo) (View Prednisolone Review and Prednisolone Label ), ZOMETA (4 Mg, Qmo) (View Zometa Review and Zometa Label ).

4668602-5 | Jaw Disorder, Osteonecrosis
Patient was taking Bendamustine (View Usage). Patient had the following side effects: jaw disorder, osteonecrosis (What is osteonecrosis?) on Nov 03, 2004 from Additional patient health information: Male patient , 88 years of age, weighting 127.9 lb, was diagnosed with plasmacytoma, metastases to bone and. Bendamustine dosage: 75 Mg, Qmo. During the same period patient was treated with PREDNISOLONE (60 Mg, Qmo) (View Prednisolone Review and Prednisolone Label ), ZOMETA (4 Mg, Qmo) (View Zometa Review and Zometa Label ).